LAMA试验五年随访:静脉腔内激光消融与机械化学消融治疗浅静脉功能不全的随机对照研究
这项随机临床试验将150例单侧症状性静脉曲张合并孤立性大隐静脉、小隐静脉或前副大隐静脉功能不全的患者等量随机分配至机械化学消融(MOCA)联合门诊静脉切除术(AP)组或静脉腔内激光消融(EVLA)联合AP组。五年随访时,EVLA组解剖闭塞率显著高于MOCA组(91% vs. 47%,p < .001),再干预率显著更低(8% vs. 21%,p = .031),但两组静脉临床严重程度评分和疾病特异性生活质量无统计学显著差异。
要点
- 五年随访EVLA组解剖闭塞率91%,显著高于MOCA组47%(p < .001)。
- EVLA组再干预率8%,显著低于MOCA组21%(p = .031)。
- 两组静脉临床严重程度评分和生活质量评分无统计学显著差异。
核心结论
- 五年随访时MOCA术后解剖闭塞率仍显著低于EVLA,导致再干预率更高;经额外干预后,两组生活质量结局无统计学显著差异。
研究设计与样本
- 随机临床试验,150例单侧症状性静脉曲张合并孤立性大隐静脉、小隐静脉或前副大隐静脉功能不全的患者等量随机分配至MOCA联合AP组或EVLA联合AP组(NCT02627846)。
- 五年随访时EVLA组75例中52例(69%)完成随访,MOCA组75例中57例(76%)完成随访。
主要发现
- EVLA组解剖闭塞率91%,MOCA组47%,EVLA显著高于MOCA(p < .001)。
- 使用EVLA而非MOCA的解剖闭塞失败绝对风险降低45%(95%置信区间29-60%)。
- EVLA组再干预率8%,MOCA组21%,EVLA显著低于MOCA(p = .031)。
- 静脉临床严重程度评分中位数(四分位距):EVLA组1(0,3)vs. MOCA组2(0,4),p = .33,无统计学显著差异。
- Aberdeen静脉曲张问卷评分中位数(四分位距):EVLA组3.06(0.6,6.4)vs. MOCA组3.63(0.0,8.6),p = .86,无统计学显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In this randomised clinical trial, patients treated with mechanochemical ablation (MOCA) with ambulatory phlebectomy (AP) had a lower anatomical occlusion (AO) rate at one year and no benefit in peri-procedural pain compared with endovenous laser ablation (EVLA) with AP. Early quality of life (QoL) improvements were similar. This study aimed to study comparative outcomes at five years. METHODS: One hundred and fifty patients with unilateral, symptomatic varicose veins in association with an isolated incompetent great saphenous vein, small saphenous vein, or anterior accessory saphenous vein were equally randomised to either MOCA or EVLA with AP (NCT02627846). Outcomes at five years included AO, need for re-intervention, venous clinical severity score (VCSS), and disease specific QoL measured by the Aberdeen Varicose Vein Questionnaire (AVVQ). RESULTS: At five years, 52 of 75 (69%) and 57 of 75 (76%) patients attended follow up in the EVLA and MOCA groups, respectively. Anatomical occlusion following EVLA was statistically significantly higher than after MOCA (91% vs. 47%; p < .001). The absolute risk reduction in failure of AO using EVLA rather than MOCA was 45% (95% confidence interval 29 - 60%). The rate of re-intervention was also statistically significantly lower following EVLA (8% vs. 21%; p = .031). There was no statistically significant difference between groups in median (interquartile range) VCSS (EVLA 1 [0, 3] vs. MOCA 2 [0, 4]; p = .33) and AVVQ (EVLA 3.06 [0.6, 6.4] vs. MOCA 3.63 [0.0, 8.6]; p = .86). CONCLUSION: Five year AO following MOCA remained significantly lower than EVLA, leading to a higher rate of re-intervention. Following these additional procedures, there was no statistically significant difference in QoL outcomes between groups.
引用
- Lim AJM, Mohamed A, Leung C, et al. Editor's Choice - Five Year Follow Up of a Randomised Clinical Trial of Endovenous Laser Ablation versus Mechanochemical Ablation for Superficial Venous Incompetence (LAMA trial). Eur J Vasc Endovasc Surg. 2025. PMID: 40288564. doi:10.1016/j.ejvs.2025.04.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。